Wells Fargo Sticks to Their Buy Rating for Dexcom (DXCM)
Wells Fargo analyst Larry Biegelsen maintained a Buy rating on Dexcom (DXCM – Research Report) yesterday and set a price target of ...
Wells Fargo Remains a Buy on Dexcom (DXCM)
Wells Fargo analyst Larry Biegelsen maintained a Buy rating on Dexcom (DXCM – Research Report) on September 13 and set a price target of ...
Sun City West Independent5d
Dexcom Brings Mentorship to Centerfield, Welcomes New, Star Athletes to Its Ground-breaking NIL Program Dexcom U
DexCom, Inc. (NASDAQ: DXCM), the global leader in real-time continuous glucose monitoring (CGM) for people with diabetes, announced today the launch of the ...
Joplin Globe13d
Dexcom CGM Worn in Outer Space as Part of First-of-its-Kind Polaris Dawn Mission
(Nasdaq: DXCM), the global leader in real-time continuous glucose monitoring for people with diabetes, today announced the Dexcom G6 Continuous Glucose Monitoring (CGM) System is being worn by ...
The Motley Fool11d
3 Reasons DexCom Looks Like a No-Brainer Buy Right Now
Investors have been bearish on DexCom's numbers all this past year. The opportunity in diabetes care, however, remains significant in the long run. The launch of glucose monitor Stelo should ...
Yahoo Finance11d
3 Reasons DexCom Looks Like a No-Brainer Buy Right Now
DexCom (NASDAQ: DXCM) is a big name in diabetes care. Its continuous glucose monitors (CGMs) help people track their blood glucose levels. But the stock has been performing poorly this year amid ...
Yahoo Finance3d
DexCom, Inc. (DXCM)
today announced the Dexcom G6 Continuous Glucose Monitoring (CGM) System is being worn by astronauts in space as part of the Polaris Dawn mission, which launched this morning and aims to better ...
The Motley Fool21d
Is DexCom a Millionaire-Maker Stock?
DexCom is one of the leaders in an industry with massive growth potential. The company is building a competitive advantage. Despite several risks, it could deliver substantial returns in the long ...
San Diego Union-Tribune23d
Dexcom starts selling its new over-the-counter glucose monitor. Here’s how much it costs
San Diego’s Dexcom began sales this week of Stelo, the industry’s first FDA-approved continuous glucose monitor that doesn’t require a prescription. With a two-pack of the biosensor costing ...
Morningstar28d
Stelo by Dexcom, the First Over-the-Counter Glucose Biosensor in the U.S., Is Now Available
Stelo is a small biosensor worn on the back of the upper arm that leverages Dexcom’s most accurate ... INDICATIONS FOR USE: The Stelo Glucose Biosensor System is an over-the-counter (OTC ...
Nasdaq21d
Is DexCom a Millionaire-Maker Stock?
Medical device specialist DexCom (NASDAQ: DXCM) is going through a rough patch. The company's shares dropped off a cliff following its second-quarter earnings report. However, zooming out helps ...
Reuters28d
Dexcom launches over-the-counter continuous glucose sensors in the US
Aug 26 (Reuters) - Dexcom (DXCM.O), opens new tab said on Monday its over-the-counter continuous glucose monitor, Stelo, is now available for use in the United States at a price of up to $99.